These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 3999223)

  • 1. Functional properties of natural killer cells in carcinoma of the prostate.
    Wirth M; Schmitz-Dräger BJ; Ackermann R
    J Urol; 1985 Jun; 133(6):973-8. PubMed ID: 3999223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural killer cell activity in the perigastric lymph nodes from patients with gastric carcinoma or benign lesions.
    Koba F; Akiyoshi T; Tsuji H
    J Clin Lab Immunol; 1987 Aug; 23(4):191-5. PubMed ID: 2959787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural killer cell activity and recycling capacity of natural killer cells in patients with carcinoma of the prostate.
    Marumo K; Ikeuchi K; Baba S; Ueno M; Tazaki H
    Keio J Med; 1989 Mar; 38(1):27-35. PubMed ID: 2716216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural killer cell activity in patients with prostatic carcinoma and its in vivo boosting with bacillus Calmette-Guérin.
    Schwemmer B; Lehmer A; Hofmann R; Braun J
    Urol Int; 1984; 39(6):321-6. PubMed ID: 6523641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural killer cell activity in tumor-draining lymph nodes: investigations in patients with malignant melanoma and head and neck cancer.
    Micksche M; Vinzenz K; Kokoschka EM; Kokoschka R
    Nat Immun Cell Growth Regul; 1985; 4(6):315-27. PubMed ID: 4088287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural killer activity and NK cytotoxic factors in peripheral blood and lymph node cells from non-Hodgkin's lymphoma patients.
    Nadkarni JJ; Mehta BA; Koppikar SB; Soman CS; Shrikhande SS; Advani SH
    Neoplasma; 1989; 36(6):701-8. PubMed ID: 2615873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of hydrocortisone on human natural killer activity and its modulation by beta interferon.
    Fuggetta MP; Graziani G; Aquino A; D'Atri S; Bonmassar E
    Int J Immunopharmacol; 1988; 10(6):687-94. PubMed ID: 3198305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural killer cell activity in patients with urologic cancer.
    Ma CP; Yu DS; Yeh MY; Chang SY; Han SH
    Eur Urol; 1987; 13(6):397-400. PubMed ID: 3428323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Native and inducible levels of natural cytotoxicity in lymph nodes draining mammary carcinoma.
    Kimber I; Moore M; Howell A; Wilkinson MJ
    Cancer Immunol Immunother; 1983; 15(1):32-8. PubMed ID: 6553505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural killer cell in systemic lupus erythematosus. Defects in effector lytic activity and response to interferon and interferon inducers.
    Sibbitt WL; Mathews PM; Bankhurst AD
    J Clin Invest; 1983 May; 71(5):1230-9. PubMed ID: 6853711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of lipopolysaccharides, lipid A and interferon on the cell-mediated cytotoxicity of human leukocytes against K-562 tumor cells.
    Fink PC; Klaproth C; Peter HH
    Infection; 1984; 12(5):322-7. PubMed ID: 6392103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell-mediated cytotoxic activity of regional lymph node cells from patients with gastric carcinoma.
    Koba F; Akiyoshi T; Arinaga S; Wada T; Tsuji H
    Jpn J Surg; 1987 Mar; 17(2):83-90. PubMed ID: 2957537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human natural cytotoxicity in the blood and lymphoid organs of healthy donors and patients with malignant disease.
    Eremin O; Ashby J; Stephens JP
    Int J Cancer; 1978 Jan; 21(1):35-41. PubMed ID: 342425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic and regional natural cytotoxicity in patients with head and neck cancer.
    Vinzenz K; Micksche M
    J Maxillofac Surg; 1986 Oct; 14(5):270-5. PubMed ID: 3464682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural cytotoxicity in draining lymph nodes of squamous cell cancer in the maxillofacial region.
    Vinzenz K; Micksche M
    J Oral Maxillofac Surg; 1987 Jan; 45(1):42-7. PubMed ID: 2432206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical features and inhibitory activity of regional lymph node cells on the cytotoxicity of autologous killer cells in patients with primary lung cancer].
    Kadoyama C; Kimura H; Yamaguchi Y
    Gan To Kagaku Ryoho; 1987 Oct; 14(10):2906-11. PubMed ID: 2959205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of natural killer activity in patients with transitional cell carcinoma of the bladder.
    Carballido J; Alvarez-Mon M; Solovera OJ; Menéndez-Ondina L; Durántez A
    J Urol; 1990 Jan; 143(1):29-33. PubMed ID: 2294256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of interferon alfa-2c on the kinetics of spontaneous cell-mediated cytotoxicity in urothelial carcinoma in vivo and in vitro.
    Grups JW; Stock T; Frohmüller HG
    Urol Res; 1988; 16(6):399-402. PubMed ID: 3232274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural killer cells in lymph nodes of healthy calves express CD16 and show both cytotoxic and cytokine-producing properties.
    Boysen P; Gunnes G; Pende D; Valheim M; Storset AK
    Dev Comp Immunol; 2008; 32(7):773-83. PubMed ID: 18177938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated prostaglandin E2 production by monocytes is responsible for the depressed levels of natural killer and lymphokine-activated killer cell function in patients with breast cancer.
    Baxevanis CN; Reclos GJ; Gritzapis AD; Dedousis GV; Missitzis I; Papamichail M
    Cancer; 1993 Jul; 72(2):491-501. PubMed ID: 8319179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.